GlassScriptPhysician profile
Jill P Trumble
NPI 1437311180
$6,639.85
in general payments reported to CMS, 2019-2025
54 companies · $973 in 2025
The $973 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,017 · 2020: $921 · 2021: $1,057 · 2022: $705 · 2023: $910 · 2024: $1,056 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,939.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,190.80 | 2021-2025 | Botox, Duopa, Ubrelvy |
| Supernus Pharmaceuticals, INC. | $590.97 | 2019-2025 | Qelbree |
| Ucb, INC. | $351.71 | 2019-2024 | Nayzilam |
| Mdd US Operations, LLC | $351.59 | 2019-2025 | Gocovri, Gocovri, Xadago |
| Emd Serono, INC. | $334.65 | 2019-2025 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $275.32 | 2019-2025 | Austedo Xr, Austedo Xr |
| Acadia Pharmaceuticals INC | $247.62 | 2019-2025 | Nuplazid |
| Neurelis, INC. | $209.81 | 2020-2025 | Valtoco |
| Kyowa Kirin, INC. | $205.55 | 2020-2025 | Nourianz |
| Allergan, INC. | $192.43 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $179.90 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $171.24 | 2020-2025 | Ingrezza |
| Amgen INC. | $150.36 | 2019-2024 | Uplizna |
| Biogen, INC. | $139.04 | 2019-2024 | Skyclarys |
| Pfizer INC. | $132.57 | 2023-2024 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Trumble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.